E

Eyenovia
D

EYEN

1.70000
USD
-0.01
(-0.58%)
Market Closed
Volume
2,749
EPS
-16
Div Yield
-
P/E
-0
Market Cap
3,559,375
Related Instruments
    IDEXUSD
    IDEXUSD
    0.007635
    (14.01%)
    0.054480 USD
    IDEXBUSD
    IDEXBUSD
    -0.000535
    (-1.08%)
    0.048810 USD
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    GOOGL
    GOOGL
    -4.895
    (-2.65%)
    179.685 USD
    N
    NIO
    0.07500
    (1.72%)
    4.44500 USD
    S
    SNDL
    0.00500
    (0.28%)
    1.77000 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    More
News

Title: Eyenovia Inc

Sector: Healthcare
Industry: Biotechnology
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.